Itch characteristics in five dermatoses: non-atopic eczema, atopic dermatitis, urticaria, psoriasis and scabies.
Texte intégral
Documents relatifs
ECLA) assessed the burden of AD using the Atopy Bur- den Score – Adult (ABS-A), a recently developed specific tool, and compared the results with those obtained with 3
Objectives To reach a consensus on how and when to measure the previously defined domain items of the TREatment of ATopic eczema (TREAT) Registry Taskforce core dataset for
described the IS use first and second-line for children with AD in a French retrospective national cohort, by using two survival analyses: ‘drug survival’ DS, defined as the duration
Multiple switches between GP2015, an etanercept biosimilar, with originator product do not impact efficacy, safety and immunogenicity in patients with chronic plaque type psoriasis:
The evalua- tion of severity of AD by PO-SCORAD is divided into several parts: surface area of skin affected by eczema, objective symptoms from 0 (non-existent) to 3 (severe):
Risk of systemic infections in adults with atopic dermatitis: a nationwide cohort study.. Catherine Droitcourt, Ida Vittrup, Sandrine Kerbrat, Alexander Egeberg, Jacob
9 In another study, more than 2700 infants in the Netherlands were enrolled in a KOALA (Child, Parent, Health, Focus on Lifestyle and Predisposition) birth
The aim was to test for a protective factor in biologic therapies as patients with moderate to severe psoriasis have been reported to be at a higher risk of